Oncogene - Table of Contents alert Volume 37 Issue 27

If you are unable to see the message below, click here to view.

Advertisement FCS2018 is jointly organized by six major research institutes in Singapore and includes an impressive line-up of speakers including two Nobel Laureates. Converging the latest cancer discoveries around the world, and the meeting promises ground-breaking and innovative insights into cancer research.  REGISTER NOW to secure your chance to interact and learn from the experts! TABLE OF CONTENTS Volume 37, Issue 27 In this issue Article Brief Communications Also new AOP Article CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis Qinglian Tang, Jinchang Lu, Changye Zou, Yang Shao, Yan Chen et al. Oncogene 2018 37 :3617 - 3630; April 03, 2018; 10.1038/s41388-018-0231-2 Abstract | Full Text cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage María Castejón-Griñán, Cecilia Herraiz, Conchi Olivares, Celia Jiménez-Cervantes & Jose Carlos García-Borrón Oncogene 2018 37 :3631 - 3646; April 06, 2018; 10.1038/s41388-018-0216-1 Abstract | Full Text NFκB regulates p21 expression and controls DNA damage-induced leukemic differentiation Claudia M. Nicolae, Michael J. O'Connor, Daniel Constantin & George-Lucian Moldovan Oncogene 2018 37 :3647 - 3656; April 06, 2018; 10.1038/s41388-018-0219-y Abstract | Full Text RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines Francesca Pentimalli, Iris M. Forte, Luca Esposito, Paola Indovina, Carmelina A. Iannuzzi et al. Oncogene 2018 37 :3657 - 3671; April 02, 2018; 10.1038/s41388-018-0214-3 Abstract | Full Text Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer Jenna H. Newman, David J. Augeri, Rachel NeMoyer, Jyoti Malhotra, Elaine Langenfeld et al. Oncogene 2018 37 :3672 - 3685; April 06, 2018; 10.1038/s41388-018-0156-9 Abstract | Full Text Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models Denise L. Crossland, Warren L. Denning, Sonny Ang, Simon Olivares, Tiejuan Mi et al. Oncogene 2018 37 :3686 - 3697; April 06, 2018; 10.1038/s41388-018-0187-2 Abstract | Full Text Rab34 regulates adhesion, migration, and invasion of breast cancer cells Lixiang Sun, Xiaohui Xu, Yongjun Chen, Yuxia Zhou, Ran Tan et al. Oncogene 2018 37 :3698 - 3714; April 06, 2018; 10.1038/s41388-018-0202-7 Abstract | Full Text Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3ß and F-box and WD repeat domain-containing 7 Ji Hoon Jung, Deok-Beom Jung, Hyunseok Kim, Hyemin Lee, Shi-Eun Kang et al. Oncogene 2018 37 :3715 - 3728; April 09, 2018; 10.1038/s41388-018-0225-0 Abstract | Full Text ΔNp73 enhances HIF-1α protein stability through repression of the ECV complex Marina Stantic, Johanna Wolfsberger, Habib A. M. Sakil & Margareta T. Wilhelm Oncogene 2018 37 :3729 - 3739; April 09, 2018; 10.1038/s41388-018-0195-2 Abstract | Full Text A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma Ismail Labgaa, Carlos Villacorta-Martin, Delia D'Avola, Amanda J. Craig, Johann von Felden et al. Oncogene 2018 37 :3740 - 3752; April 09, 2018; 10.1038/s41388-018-0206-3 Abstract | Full Text Brief Communications WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma Dario Zimmerli, Virginia Cecconi, Tomas Valenta, George Hausmann, Claudio Cantù et al. Oncogene 2018 37 :3753 - 3762; April 17, 2018; 10.1038/s41388-018-0244-x Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.